SYNAPTICS Inc — Director's Dealing 2020

Aug 12, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SYNAPTICS Inc (SYNA)
CIK: 0000817720
Period of Report: 2020-08-10

Reporting Person: CHAN NELSON C (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-08-10	Common Stock	M	4500	$46.50	Acquired	60993	Direct
2020-08-10	Common Stock	S	18968	$85.4588	Disposed	42025	Direct
2020-08-10	Common Stock	S	8013	$86.1216	Disposed	34012	Direct
2020-08-10	Common Stock	S	1850	$87.8665	Disposed	32162	Direct
2020-08-10	Common Stock	S	419	$88.99	Disposed	31743	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-08-10	Director Stock Option (Right to Buy)	$46.50	M	4500	Disposed	2020-10-28	Common Stock (4500)	Direct

Footnotes

F1: The shares were sold pursuant to a 10b5-1 Trading Plan dated May 29,2020.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.81 to $85.80, inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.82 to $86.71, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.55 to $87.96, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F5: 1/12th of the total number of shares subject to the option vested and became exercisable on the 28th day of each month following the October 28, 2013 date of grant, until fully vested on October 28, 2014.